# Niacin Supplementation Alleviates TCIPP-Induced Lung Injury via Inhibition of the NF-κB Signaling Pathway

**Authors:** Meiyu Zhou, Xiaoyu Gao, Ruiyang Tian, Taiyu Gu, Ziwei Dong, Wenjun Shi, Tianyao Mao, Zhengdong Zhang, Haiyan Chu

PMC · DOI: 10.3390/antiox15010085 · Antioxidants · 2026-01-08

## TL;DR

Niacin helps protect against lung damage caused by TCIPP, an environmental pollutant, by reducing inflammation and oxidative stress.

## Contribution

Niacin's protective role against TCIPP-induced lung injury via NF-κB inhibition is newly demonstrated in both human and animal studies.

## Key findings

- Higher niacin intake was linked to better lung function in humans with lower TCIPP exposure.
- Niacin reduced TCIPP-induced lung injury in mice by inhibiting NF-κB and oxidative stress.
- Niacin supplementation improved antioxidant defenses and lung function in exposed mice.

## Abstract

Tris(1-chloro-2-propyl) phosphate (TCIPP) is an emerging environmental pollutant associated with adverse respiratory effects, yet whether niacin has a protective effect on lung function remains unclear. Data from 1031 participants in the 2011–2012 National Health and Nutrition Examination Survey (NHANES) were analyzed using multiple linear regression to assess associations between urinary bis(1,3-dichloro-2-propyl) phosphate (BCIPP), dietary niacin intake, and pulmonary function. Animal models were established to investigate TCIPP-induced lung injury and the protective effects of niacin. Lung injury was assessed by histopathology, lung function, inflammation, and oxidative stress-related indicators. Comparative Toxicogenomics Database (CTD), molecular docking, and Western blot were performed to explore underlying mechanisms. Higher urinary BCIPP concentration was associated with reduced lung function, whereas higher dietary niacin intake was associated with improved lung function. Notably, BCIPP levels showed positive associations between dietary niacin intake and FEV1 [β (95% CI) = 0.11 (0.06, 0.16), padj < 0.001] and FVC [β (95% CI) = 0.09 (0.05, 0.13), padj < 0.001] in males with lower BCIPP exposure. In male mice, TCIPP exposure caused dose-dependent lung injury, inflammation, and oxidative stress, while niacin supplementation alleviated lung damage, improved lung function, and restored antioxidant defenses by inhibiting NF-κB phosphorylation. Niacin supplementation alleviated TCIPP-induced lung injury in males by inhibiting oxidative stress and NF-κB activation, suggesting niacin as a potential nutritional strategy to improve lung function.

## Linked entities

- **Proteins:** NFKB1 (nuclear factor kappa B subunit 1)
- **Chemicals:** TCIPP (PubChem CID 26176), niacin (PubChem CID 938)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** inflammation (MESH:D007249), lung damage (MESH:D008171), Lung Injury (MESH:D055370), reduced lung function (MESH:D001523)
- **Chemicals:** BCIPP (MESH:C000629391), Niacin (MESH:D009525), Tris(1-chloro-2-propyl) phosphate (MESH:C072782), TCIPP (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12837827/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12837827/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC12837827/full.md

---
Source: https://tomesphere.com/paper/PMC12837827